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ABSTRACT 37 
Background: Clinical decision-making in total knee arthroplasty (TKA) is a complex process 38 
needing further clarification. The aim of this study was to compare TKA eligibility criteria 39 
considered most important by orthopaedic surgeons (OS) to characteristics of patients with knee 40 
osteoarthritis (OA) eventually found eligible for TKA. 41 
Methods: Nine OS chose the five criteria most important when deciding on TKA eligibility. Cross-42 
sectional data from 200 patients found either eligible (n=100) or not eligible (n=100) for TKA by 43 
one of the nine OS, were analyzed in a regression analyses with TKA eligibility as the dependent 44 
variable.  45 
Results: Radiographic severity (n=8), pain (n=9), functional disability (n=8) and not responding to 46 
the recommended non-surgical treatment (n=7) were considered most important by OS.  47 
Associations (P<0.25) between TKA eligibility and criteria found important by the OS were 48 
demonstrated for worse radiographic severity and more functional limitations, but not for pain and 49 
not responding to the recommended non-surgical treatment. 50 
Furthermore, more comorbidities and higher BMI were associated with TKA-eligibility, but not 51 
found important for TKA eligibility by the OS.  52 
Conclusion: Radiographic severity and functional limitations were confirmed as drivers for TKA 53 
eligibility, while pain was not. Not responding to non-surgical treatment was not included in the 54 
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decision-making, suggesting low uptake of clinical guidelines in clinical practice. This study 55 
highlights the complexity of the decision-making with some overlap between the criteria that OS 56 
think they apply and what is actually applied in clinical practice. 57 
Keywords: Osteoarthritis; Knee; Decision-making; Arthroplasty; Therapeutics. 58 
 59 
1. INTRODUCTION 60 
The incidence of total knee arthroplasty (TKA) in the US has increased markedly from 31.2 per 61 
100.000 person-years in 1971-76 to 220.9 in 2005-2008 [1], and is expected to increase by almost 62 
700% towards 2030 [2].  63 
TKA is an effective treatment of end-stage knee osteoarthritis (OA) [3]. However, a systematic 64 
review have demonstrated that 20% undergoing TKA experience only small or no improvements in 65 
pain [4], and more knee pain is known to be related to lower patient satisfaction [5]. One possible 66 
way to improve patient outcomes after TKA would be to refine eligibility criteria in order to select 67 
patients that are more likely to benefit from the procedure.  68 
Clinical disease severity in patients undergoing total joint arthroplasty is known to vary between 69 
countries [6]. Although patients found eligible for TKA and total hip arthroplasty (THA) have more 70 
severe pain and functional limitations than patients not eligible, there is a considerable overlap in 71 
patient status, even when adjusting for radiographic severity, thereby making it impossible to 72 
establish cut-off values for eligibility for arthroplasty [7]. This could be due to the fact that pain, 73 
disability and radiographic severity poorly reflect the complexity of decision-making when the 74 
orthopaedic surgeon (OS) evaluates eligibility for TKA/THA [3,6,8].  75 
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Other criteria considered important for TKA eligibility and/or suggested in the literature to affect 76 
the decision-making are: Not responding to the recommended non-surgical treatments [3], duration 77 
of symptoms [9], being medically fit [3,10], age [3,9] and Body Mass Index (BMI) [3,9]. However, 78 
no reports exist on whether criteria considered important for TKA eligibility are actually applied in 79 
clinical practice, or which combination of criteria best reflect the complexity of the decision on 80 
eligibility. Studies on this topic would improve the understanding of the decision-making process 81 
and should be accompanied by an investigation of how patient preferences affect whether or not 82 
they choose to proceed with surgery. 83 
Therefore, the purpose of this study was to compare criteria regarded important by OS when 84 
deciding on TKA eligibility to characteristics of patients with knee OA who were actually found 85 
eligible for TKA by the same OS. Our primary hypothesis was that the eligibility criteria considered 86 
important by OSs and the patient characteristics actually associated with TKA eligibility would be 87 
the same, and that a combination of criteria would explain most of the variance in TKA eligibility. 88 
 89 
2. MATERIAL AND METHODS 90 
2.1. Study design 91 
This was a cross-sectional study conforming to the STROBE statement for reporting cross-sectional 92 
studies [11]. 93 
2.2. Participants 94 
Baseline data from 200 patients with knee OA (confirmed by radiography) enrolled in one of two 95 
randomized controlled trials (RCT) investigating the effectiveness of TKA (n=100) [12] and non-96 
surgical treatments (n=100) [13] between September 2011 and December 2013 were analyzed. All 97 
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patients were referred from primary care to an OS in one of two specialized public hospital units in 98 
The North Denmark Region for evaluation of TKA eligibility.  99 
The main difference between the two RCT populations was eligibility for TKA, with one including 100 
only patients eligible [12] and the other only patients not eligible for TKA [13]. For a full list of 101 
eligibility criteria, see the published study protocols [12,13].  102 
Ethics approval was obtained for both RCTs from the Ethics Committee of The North Denmark 103 
Region (N-20110024 and N-20110085) and both trials were registered on ClinicalTrials.gov 104 
(NCT01410409 and NCT01535001). 105 
2.3. Outcome Variable 106 
Eligibility for TKA (yes/no) as assessed by the OS was the outcome variable, dividing the study 107 
population into two equally sized groups (n=100). 108 
2.4. Predictor criteria for the decision on TKA eligibility 109 
A list of ten potential criteria influencing the OS’ decision on whether or not patients with knee OA 110 
are eligible for TKA was defined by the authors of the study based on recent recommendations [3], 111 
a review of the literature, and from interviews with two high-volume OS: 1) radiographic severity 112 
of the knee OA, 2) knee pain during several activities of daily living (Knee pain during ADL), 3) 113 
knee pain at night, 4) knee pain demanding morphine or morphine-like drugs, 5) functional 114 
limitations in daily activities due to the knee OA (functional limitations), 6) not responding to the 115 
recommended non-surgical treatment, 7) duration of symptoms, 8) comorbidities, 9) age, and 10) 116 
BMI (Table 1). The criteria were assessed as part of the baseline assessment when the participants 117 
were enrolled in the RCTs.  118 
2.5. Statistical analyses 119 
Surgery or no surgery –criteria influencing the orthopaedic surgeon’s decision 
 
 
6 
 
 
 
The 200 patients allowed us to conduct the analyses using a minimum of 20 predictor variables 120 
[20]. We decided only to apply 10 variables.  121 
2.5.1. Model including criteria considered important by orthopedic surgeons for TKA 122 
eligibility 123 
All nine OS involved in recruiting patients for the two RCTs were asked to choose the five most 124 
important criteria which they applied when deciding on TKA eligibility and prioritize them 125 
according to the importance of each individual criterion. Criteria regarded important by at least half 126 
of the nine OS (n≥5) were included in one multivariable model (the surgeon-based model). 127 
2.5.2. Model including characteristics of patients found eligible 128 
Furthermore, univariable and multivariable logistic regression analyses were applied to investigate 129 
whether the a priori hypothesized predictor criteria for TKA eligibility were actually associated 130 
with TKA eligibility. The construction of this model (the statistically-based model) followed the 131 
construction proposed by Bursac et al. [21]. Criteria with a P<0.25 in the univariable analyses were 132 
included in another multivariable analysis, since traditional levels can fail in identifying important 133 
criteria [21]. A criterion included in the first model was removed if P≥0.10 and changing the 134 
estimate of the other criteria <20%. Criteria not selected for the first model due to (P≥0.10) in the 135 
univariable analyses were re-entered into the model one at a time to identify criteria that contributed 136 
to the model in the presence of the other criteria. If a criterion had a P-value<0.10, it was kept in the 137 
final model. The significance level of the final regression model was set at P<0.05.  138 
A priori, possible interactions were defined between the following criteria: 2 and 3, 2 and 4, 3 and 139 
4, 2 and 5, 2 and 10, 5 and 10, 5 and 8, and 8 and 10. These interactions were tested in both the 140 
model based on criteria considered important by the OS for TKA eligibility and the model based on 141 
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characteristics of patients found eligible for TKA if both interacting criteria were in the model. The 142 
interaction was kept in the final models if P<0.10 or changing the estimate of the other criteria 143 
>20%. 144 
Odds ratios (OR) were used to assess the association between each predictor criterion and TKA 145 
eligibility and Nagelkerke’s R2 was used to compare the performance of each of the predictor 146 
criteria and a as measure of overall performance of both of the models (explained variation, i.e. how 147 
good the model fits the data).  148 
 149 
3. RESULTS 150 
Demographic variables for the participants are presented in table 2. BMI data from eight 151 
participants (four eligible and four not eligible for TKA) was missing. Therefore these participants 152 
were excluded, and a total of 192 patients were included in the analyses. 153 
3.1. Model including criteria considered important by orthopedic surgeons for TKA eligibility 154 
The OS’ prioritization is presented in table 3. One OS stated that findings from the clinical 155 
examination were also important when deciding upon eligibility. Four criteria were regarded as 156 
important when deciding on TKA eligibility by at least half of the OS: radiographic severity of the 157 
knee OA (n=8), knee pain during ADL (n=9), functional limitations (n=8) and not responding to the 158 
recommended non-surgical treatment (n=7). These criteria were included in the surgeon-based 159 
model (Table 5). The model accounted for 23% of the variance in TKA eligibility (Nagelkerke’s R2 160 
= 0.228, P<0.001).  161 
3.2. Model including characteristics of patients found eligible 162 
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 In the univariable analyses worse radiographic OA severity, worse pain during ADL, morphine 163 
usage, more functional limitations, more comorbidities and higher BMI were associated with being 164 
eligible for TKA (Table 4). The model including criteria associated with TKA eligibility in the 165 
univariable analyses (Table 5) consisted of radiographic severity, functional limitations, 166 
comorbidities, and BMI. This model significantly accounted for 27% of the variance in TKA 167 
eligibility (Nagelkerke’s R2 = 0.267, P<0.001).  168 
No interactions were found in neither of the models (P>0.10 and changing the estimates <20%). 169 
 170 
4. DISCUSSION 171 
Radiographic severity and functional limitations were confirmed as drivers for TKA eligibility, 172 
while pain and not responding to the recommended non-surgical treatment were found important by 173 
the OS but not associated with TKA eligibility. When combined in a model, criteria associated with 174 
TKA eligibility in the univariable analyses (radiographic severity, functional limitations, 175 
comorbidities and BMI) only accounted for 27% of the variance in TKA eligibility and only 23% of 176 
the variance was accounted for when including the criteria found important by at least half of the 177 
OS in a model. This study highlights that the decision on TKA eligibility is a multifactorial process 178 
with some overlap between the criteria that OS consider important and what they actually apply in 179 
clinical practice. 180 
4.1. Non-surgical treatment before TKA 181 
Most of the OS (n=7) found not responding to the recommended non-surgical treatment to be 182 
important for their decision on TKA eligibility. However, it was not associated with TKA 183 
eligibility. Even though being a recognized eligibility criterion for TKA [3] it is well known that 184 
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clinical practice does not reflect the recommendations [22-25]. In a study from the US using data 185 
from the United Healthcare Database only 10% undergoing TKA in 2009 had participated in 186 
rehabilitation in the preceding five years [23], while 3% had received a mechanical intervention, 187 
such as a knee brace, and 44% an intra-articular corticosteroid injection [23]. Results from a recent 188 
systematic review and meta-analysis summarizing studies using quality indicators to assess the 189 
quality of care in OA confirmed the suboptimal care of OA patients for both pharmacological and 190 
non-pharmacological treatments [25]. The study found pass rates, defined as the percentage of 191 
patients receiving appropriate care according to guidelines, of only 37.5% (95% CI 30.8–44.5%) 192 
and 36.1% (95% CI 27.8-44.7%), respectively, for pharmacological and non-pharmacological 193 
treatment of OA [25]. Therefore, the lack of association between TKA eligibility and not 194 
responding to the recommended non-surgical treatment could merely be a result of lack of 195 
adherence to the recommended non-surgical treatment. The implementation of evidence-based 196 
guidelines in clinical practice is challenging due to a wide range of barriers and requires a 197 
comprehensive approach tailored to the specific settings and target groups to succeed [26]. 198 
Nationwide initiatives comprising training of physical therapists to deliver evidence-based, 199 
individualized exercise and education to OA patients [27] in combination with information and 200 
education of other health care professions and the population have been successfully introduced in 201 
Denmark[28] and Sweden[29], and represents a way to improve adherence to OA guidelines.  202 
4.2. Is pain less important for TKA eligibility? 203 
Pain was not associated with TKA, even though all OS (n=9) found it to be important for their 204 
decision on TKA eligibility, supported by the results from a study on THA eligibility [30]. The OS 205 
in our study prioritized pain as the most important, and functional limitations as the second most 206 
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important criterion, while radiographic severity was only third. However, looking at the explained 207 
variation from the univariable analyses pain and functional limitations explained less variation in 208 
TKA eligibility than both comorbidities and BMI with radiographic severity explaining most of the 209 
variation in TKA eligibility. Since pain is considered one of the key criteria for TKA eligibility 210 
[3,7,9,10,31], it was expected that it would be one of the most important predictor criteria. 211 
However, our study highlights that pain is not the only criterion important for TKA eligibility 212 
[7,32,33] and it could be so that while pain is an important criterion for TKA eligibility pain 213 
severity is not as important as other influencing criteria [8]. This is supported by our results and 214 
underlines the importance of not restricting TKA to one type of patient over another based on one 215 
criterion alone [8]. Another potential explanation could be, that one of the exclusion criteria for 216 
both studies from which the current patient population was drawn was knee pain >60 mm on a 100 217 
mm VAS. This could affect the results, since patients eligible for TKA presumably have higher pain 218 
scores than patients not eligible for TKA thereby excluding some patients eligible for TKA from 219 
this analysis.  220 
4.3. Age, BMI and comorbidities 221 
Interestingly, age was not associated with eligibility and higher BMI and more comorbidities were 222 
associated with eligibility for TKA, even though patients being morbidly obese or of less than 55 223 
years have demonstrated more variable outcome following TKA than patients with lower BMI and 224 
older than 55 years [34-40]. However, since most patients in the present study had few 225 
comorbidities and were not morbidly obese or younger than 55 the lack of association with age and 226 
conflicting association with BMI and comorbidities could be a result of this age-restricted study 227 
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population. Furthermore, it is important to recognize, that even though being risk factors for poorer 228 
outcome, neither age nor BMI are contraindications for TKA [3]. 229 
4.4. Consensus criteria for TKA eligibility are needed 230 
In agreement with current recommendations [3] the OS in our study regarded pain, function, 231 
radiographic severity and not responding to non-surgical treatment to be important for their decision 232 
on TKA eligibility. However, the analyses showed that more severe radiographic severity, greater 233 
functional limitations, more comorbidities and higher BMI were the patient characteristics actually 234 
associated with TKA eligibility. This is similar to the findings from a study on eligibility for THA, 235 
where severe cardiovascular disease, quality of life with regards to physical function, and 236 
radiographic OA severity were related to eligibility for THA when combined in a model [30]. The 237 
model based on patient characteristics associated with TKA eligibility accounted for only 27% of 238 
the variance in TKA eligibility, while the model based on criteria found important by at least half of 239 
the OS accounted for only 23% of the variance, thereby leaving about 75% of the variance in TKA 240 
eligibility unaccounted for. Including patient preferences could potentially improve this, since it is 241 
known to affect whether or not patients undergo total joint arthroplasty [41]. Since our study did not 242 
evaluate whether or not the participants underwent TKA, but if they were found eligible for TKA 243 
by the OS, the authors believe that not including patient preferences in the analyses was 244 
appropriate. Future studies should evaluate the effects of patient preferences on whether or not the 245 
procedure is actually performed. Furthermore, additional unknown criteria influence the decision-246 
making and points out that consensus on the indications for TKA is highly demanded with the 247 
possibility to better identify patients that will benefit from the procedure [8] and potentially improve 248 
outcomes following TKA further.  249 
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4.5. Limitations 250 
Our results should be evaluated with respect to some limitations. Firstly, the exclusion criteria knee 251 
pain >60 mm on a 100 mm VAS applied in both studies could be a limitation to the study. Since 252 
severe knee pain is considered an important indication for TKA [3], the lack of associations 253 
between pain and TKA in our study could merely be the result of not including those with more 254 
severe pain. However, KOOS pain scores of both the patients eligible and not eligible for a TKA in 255 
our study (mean scores of 49 and 53 respectively on a 0-100 worst to best scale) were comparable 256 
to previous pre-surgery pain scores of patients eligible for TKA [7,42]. Secondly, this study did not 257 
have the power to assess inter-surgeon variability or the predictive capacity of the model with 258 
regards to the individual OS. This could have increased the internal validity of the findings, since it 259 
would give the possibility to compare the criteria found most important by the individual OS to the 260 
criteria associated with his/her decision on TKA eligibility. Thirdly, the criteria applied in our study 261 
were not restricted to local surgeon-specific criteria. We applied questionnaires reflecting pain, 262 
function and comorbidities not necessarily used by the individual OS. Since wide variations in pain 263 
[7,31,32], function [7,31,32] and comorbidities [31] have been demonstrated among countries, 264 
centers and OS when deciding on TKA eligibility we decided to use valid, reliable and recognized 265 
measures. We believe this increases the external validity of the results instead of applying a local 266 
set of measures not generalizable to other centers and countries. Future studies should elucidate 267 
whether the findings are similar in other countries.  268 
5. CONCLUSIONS 269 
While the OS agreed on radiographic severity, pain, functional limitations and not responding to 270 
non-surgical treatment being the most important criteria for TKA eligibility, corresponding to 271 
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recommendations in clinical guidelines, some discrepancy was found between these criteria and 272 
what was actually applied by the same OS in clinical practice. Radiographic severity and functional 273 
limitations were confirmed as drivers for TKA eligibility, while pain was not. This may be because 274 
our study population did not include knee OA patients with severe pain. However, pain scores of 275 
our study population was comparable to previous pre-surgery pain scores of patients eligible for 276 
TKA [7,42]. Patients found eligible for TKA had more comorbidities and higher BMI, contrary to 277 
the criteria found most important by surgeons. Having had, and not responding to, non-surgical 278 
treatment was not included in the decision-making, suggesting low uptake of clinical guidelines in 279 
clinical practice.  280 
This study highlights the complexity of the decision-making on TKA eligibility in clinical practice, 281 
since about 75% of the variance in eligibility remains unexplained by the criteria found most 282 
important by the OS and the characteristics of those actually found eligible.  283 
 284 
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TABLES 428 
Table 1. Description of predictor criteria for TKA eligibility used in the regression analyses 
Criterion Assessment method Dichotomization A priori hypothesis 
Radiographic 
severity  
Semiflexed posteroanterior 
radiographs recorded in standing 
position (on both legs) with feet 
pointing forward and hips in 
neutral ab- and adduction. The 
X-ray beam was centered at the 
level of the knee joint with a 
tube to film distance of 100 cm. 
Radiographic severity was 
assessed by the surgeon using 
the original Kellgren-Lawrence 
scale (K&L) [14,15].  
Yes, into low (K&L 1-2) and 
high (K&L 3-4) K&L score 
A high K&L score 
is associated with 
being eligible for 
total knee 
arthroplasty (TKA).  
 
Knee pain 
during ADL 
This was assessed using the 
subscale Pain from the KOOS 
[16,17] 
No A worse KOOS 
Pain score is 
associated with 
being eligible for 
TKA.  
Knee pain at 
night 
The participants rated their pain 
on a 100mm VAS in response to 
the question: “How much knee 
pain do you have at night?”. 
Yes, into pain (VAS≥10) and 
no pain (VAS<10) at night 
Pain at night is 
associated with 
being eligible for 
TKA. 
Knee pain 
demanding 
morphine or 
morphine-like 
drugs. 
The participants were asked to 
give information on any pain 
killers used because of knee 
pain. 
Yes, into using morphine or 
morphine-like drugs (yes/no) 
The need for 
morphine or 
morphine-like drugs 
to relieve the knee 
pain is associated 
with being eligible 
for TKA. 
Functional 
limitations 
This was assessed using the 
subscale ADL (Function in daily 
living) from the KOOS [16,17] 
No A worse KOOS 
ADL score is 
associated with 
being eligible for 
TKA. 
Not responding 
to the 
recommended 
non-surgical 
treatment 
This implies that the participant 
had undergone the core 
treatments of OA (exercise, 
education and weight loss (if 
needed)) [18] before being 
referred to the orthopedic 
surgeon. This was evaluated 
from questions on previous 
treatments held together with the 
Yes, participants who had 
undergone the recommended 
non-surgical treatment without 
sufficient effect were rated as 
“not responding” while the rest 
were rated as “has not yet tried 
the recommended non-surgical 
treatment”. 
Not responding to 
non-surgical 
treatment is 
associated with 
being eligible for 
TKA. 
 
Surgery or no surgery –criteria influencing the orthopaedic surgeon’s decision 
 
 
20 
 
 
 
referral to the orthopedic surgeon 
due to continuous symptoms- 
Duration of 
symptoms 
This was evaluated using the 
question: “When did your knee 
symptoms begin?”. The 
participants chose one of the 
following categories: 0-6 months 
ago, 6-12 months ago, 1-2 years 
ago, 2-5 years ago, 5-10 years 
ago, or more than 10 years ago.  
No A longer duration of 
symptoms is 
associated with 
being eligible for 
TKA. 
 
Comorbidities Comorbidities were registered 
using the Charlson Comorbidity 
Index [19]. 
Yes, the index was 
dichotomized (0-1 and 2 or 
above) due to the non-linearity 
of the index and since an 
univariable analysis showed 
that there was no difference 
between 0 and 1 comorbidities, 
but between 0 and 2 
comorbidities with respect to 
their association with the 
outcome variable. 
Having 
comorbidities is 
inversely associated 
with being eligible 
for TKA, since 
being medically fit 
is important when 
considering surgery 
[3] 
Age Age in years No Increasing age is 
associated with 
being eligible for 
TKA. 
Body Mass 
Index (BMI) 
Height (seca 213, seca gmbh & 
co. kg., Hamburg, Germany) and 
weight (seca 813, seca gmbh & 
co. kg., Hamburg, Germany) 
were assessed in a standardized 
way to calculate BMI. 
No Increasing BMI is 
inversely associated 
with being eligible 
for TKA, since 
obesity is known to 
affect outcome 
variability [3] 
 429 
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 431 
 432 
Surgery or no surgery –criteria influencing the orthopaedic surgeon’s decision 
 
 
21 
 
 
 
Table 2. Demographic variables for patients eligible (n=100) and not eligible (n=100) for total knee 
Arthroplasty (TKA)* 
Variable 
Patients eligible for a 
TKA 
Patients not eligible for a 
TKA 
Women, n (%) 62 (62) 51 (51) 
Age (years), mean (SD) 66.4 (8.7) 66.0 (8.9) 
Radiographic severity, n (%) 
     Grade 1-2 
     Grade 3-4 
 
12 (12) 
88 (88) 
 
46 (56) 
54 (54) 
Knee pain during ADL, mean (SD) 49.1 (15.4) 52.6 (14.0) 
Knee pain at night, n (%) 83 (83) 78 (78) 
Using morphine because of knee, n (%) 17 (17) 11 (11) 
Functional limitations, mean (SD) 54.3 (16.6) 57.9 (16.8) 
Not responding to the recommended non-surgical 
treatment, n (%) 
6 (6) 10 (10) 
Duration of symptoms, n (%) 
     0-6 months 
     6-12 months 
     1-2 years 
     2-5 years 
     5-10 years 
     More than 10 years  
 
6 (6) 
7 (7) 
16 (16) 
25 (25) 
23 (23) 
23 (23) 
 
6 (6) 
15 (15) 
15 (15) 
24 (24) 
12 (12) 
28 (28) 
Charlson Comorbidity Index, n(%) 
     0-1 
     2 or above 
 
73 (73) 
27 (27) 
 
85 (85) 
15 (15) 
Body Mass Index, mean (SD) 32.2 (6.0) 30.0 (5.4) 
* Radiographic severity: Radiographic knee osteoarthritis severity on the Kellgren-Lawrence scale; Knee 
pain during ADL: The subscale Pain from the Knee Injury and Osteoarthritis Outcome Score (KOOS); Knee 
pain at night: The participants rated their pain on a 100mm visual analogue scale (VAS) in response to the 
question: “How much knee pain do you have at night?”. This was dichotomized into pain (VAS≥10) and no 
pain (VAS<10) at night. Functional limitations: The subscale ADL from KOOS; Not responding to the 
recommended non-surgical treatment: Recommended non-surgical treatment was defined as the core 
treatments of OA (exercise, education and weight loss (if needed); Body Mass Index was only available for 
96 participants from each group. 
 433 
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Table 3: The orthopaedic surgeons’ (n=9) prioritization of criteria they use when deciding on 
eligibility for total knee arthroplasty* 
 
Prioritization (number of orthopaedic 
surgeons) 
Criteria 1 2 3 4 5 
Radiographic severity 2 2 3 0 1 
Knee pain during ADL 6 2 1 0 0 
Knee pain at night 0 1 1 2 0 
Using morphine because of knee 0 0 1 1 1 
Functional limitations 0 4 2 2 0 
Not responding to the recommended non-surgical treatment 0 0 1 2 4 
Duration of symptoms  0 0 0 0 2 
Comorbidities 1 0 0 0 2 
Age 0 0 0 1 0 
Body Mass Index 0 0 0 1 0 
* One orthopaedic surgeon (OS) did not choose one of the ten criteria as prioritization number 4. One OS 
chose both age and body mass index as prioritization number 4. One OS chose both radiographic severity 
and duration of symptoms as prioritization number 5. See table 1 + 2 for further explanations.  
Surgery or no surgery –criteria influencing the orthopaedic surgeon’s decision 
 
 
23 
 
 
 
 446 
 447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
Table 4: Univariable logistic regression of associations between eligibility for total knee arthroplasty 
(TKA) and the predictor criteria for TKA eligibility* 
Predictor criteria OR 95% CI R2 P 
Radiographic severity (low K&L score as reference category) 6.25 3.04-12.83 0.183 <0.001 
Knee pain during ADL 0.98 0.97-1.00 0.019 0.09 
Knee pain at night (compared to no pain at night) 1.38 0.68-2.79 0.005 0.37 
Using morphine because of knee (compared to not using morphine) 1.66 0.73-3.75 0.010 0.23 
Functional limitations 0.99 0.97-1.00 0.017 0.11 
Not responding to the recommended non-surgical treatment (compared 
to “has not yet tried the recommended treatment”) 
0.57 0.20-1.65 0.007 0.30 
Duration of symptoms (0-6 months as the reference category) 
      6-12 months 
      1-2 years 
      2-5 years 
      5-10 years 
      More than 10 years 
----- 
0.47 
1.07 
1.04 
1.92 
0.82 
----- 
0.11-1.98 
0.28-4.05 
0.30-3.68 
0.51-7.24 
0.23-2.89 
0.046 
----- 
----- 
----- 
----- 
----- 
----- 
0.30 
0.92 
0.95 
0.34 
0.76 
Comorbidities (0-1 comorbidities as reference category) 2.10 1.04-4.24 0.029 0.04 
Age 1.01 0.97-1.04 0.001 0.73 
Body Mass Index 1.07 1.02-1.13 0.048 0.01 
*OR = odds ratio; 95% CI = 95% confidence interval; R2 =  Nagelkerke’s R2 (explained variation); K&L =  
Kellgren-Lawrence scale. See table 1 + 2 for further explanations.  
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Table 5: Multivariable logistic regression model of associations between eligibility for total knee 
arthroplasty (TKA) and the predictor criteria for TKA eligibility* 
Predictor criteria OR 95% CI P 
Model based on criteria found important by the at least half of the surgeons    
Radiographic severity (low K&L score as reference category) 7.60 3.54-16.34 <0.001 
Knee pain during ADL 0.99 0.96-1.02 0.61 
Functional limitations 0.98 0.95-1.01 0.16 
Not responding to the recommended non-surgical treatment (compared to “has not 
yet tried the recommended treatment”) 
0.54 0.17-1.72 0.30 
Model based on criteria associated with eligibility in the univariable analysis    
Radiographic severity (low K&L score as reference category) 7.82 3.51-17.42 <0.001 
Functional limitations 0.98 0.96-1.00 0.048 
Comorbidities (0-1 comorbidities as reference category) 2.19 0.96-5.02 0.06 
Body Mass Index 1.05 0.99-1.12 0.08 
*OR = odds ratio; 95% CI = 95% confidence interval; K&L = Kellgren-Lawrence scale. See table 1+ 2 for further 
explanations.  
